Despite the potential benefits of inhibiting Grb14 in disease settings, one study has shown that the global Grb14 KO mice have cardiac hypertrophy accompanied by impaired cardiac function, raising the potential safety concern for developing therapies of inhibiting Grb14 activity. This evidence concerns the gene GRB14 and cardiac hypertrophy.